ArriVent BioPharma Total Risk Alpha
| AVBP Stock | | | 24.10 -0.51 -2.07% |
ArriVent BioPharma total risk alpha lookup summarizes this and related technical indicators for ArriVent BioPharma Common. Data availability can vary by region and feed;
Equity Screeners provides broader screening access. ArriVent BioPharma has a market cap of 1.09 B, ROE of -58.88%. Use
Trending Equities to explore allocation context. This includes a position in ArriVent BioPharma Common inside the allocation mix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of labor statistics.
ArriVent BioPharma Common has current Total Risk Alpha of 0.1658. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | 0.1658 | |
| ER[a] | = | Expected return on investing in ArriVent BioPharma |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on ArriVent BioPharma |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
ArriVent BioPharma Total Risk Alpha Peers Comparison
ArriVent Total Risk Alpha Relative To Other Indicators
ArriVent BioPharma Common is rated
below average. in total risk alpha category among its top competitors. It is currently under evaluation. in maximum drawdown category among its top competitors reporting about
109.48 of Maximum Drawdown per Total Risk Alpha. The ratio of Maximum Drawdown to Total Risk Alpha for ArriVent BioPharma Common is roughly
109.48 The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.